Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.32 |
| ▸ | RAC3 | P60763 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 1/20 | 0.32 |
| ▸ | RAC1 | P63000 | 1/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12691123 | 0.97 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL12175739 | 0.97 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL22595563 | 0.96 | KDM4E (0.39) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL12690900 | 0.96 | KDM4E (0.40) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL22596550 | 0.94 | KDM4E (0.40) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL17809394 | 0.94 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMKMT2AMEN1 | |
| SCHEMBL22596520 | 0.93 | KDM4E (0.38) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL22596050 | 0.93 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL17809295 | 0.93 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMGABRG2GABRB3 | |
| SCHEMBL26841758 | 0.92 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMGABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962158-B2 | Material having indolocarbazole compound for phosphorescent light-emitting element and organic electroluminescent element using the same | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2015-02-24 | — | — | US | disclosed |
| US-8962158-B2 | Material having indolocarbazole compound for phosphorescent light-emitting element and organic electroluminescent element using the same | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20120001165-A1 | MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2012-01-05 | — | — | US | disclosed |
| US-20120001165-A1 | MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001165-A1 | MATERIAL FOR PHOSPHORESCENT LIGHT-EMITTING ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | LEF1, ELOC, ELP1 | L3MBTL1 253/4885KDM4E 3299/4885ATM 3061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.